Back
Catalyst Pharmaceuticals Stock Price Chart
Trump's Tariffs Are Reshaping Markets
Grade any 3 stocks FREE to see if your portfolio is at risk.
Buy
84
CPRX
Catalyst Pharmaceuticals
Last Price:
$25.36
Seasonality Move:
34.82%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight buying pressure.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.81 | Buy |
| 20-day SMA: | 24.24 | Buy |
| 50-day SMA: | 23.77 | Buy |
| 200-day SMA: | 22.06 | Buy |
| 8-day EMA: | 24.83 | Buy |
| 20-day EMA: | 24.3 | Buy |
| 50-day EMA: | 21.15 | Buy |
| 200-day EMA: | 9.81 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.79 | Buy |
| Relative Strength Index (14 RSI): | 62.19 | Buy |
| Chaikin Money Flow: | 314522 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.59 - 24.87) | Buy |
| Bollinger Bands (100): | (21.88 - 24.32) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 25.29 while CPRX 8-day simple moving average is 24.81, which is a Buy signal.
-
The stock price of CPRX is 25.29 while Catalyst Pharmaceuticals 20-day SMA is 24.24, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day simple moving average is 23.77 while CPRX share price is 25.29, making it a Buy technically.
-
CPRX stock price is 25.29 and Catalyst Pharmaceuticals 200-day simple moving average is 22.06, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
84
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $25.29. The Score for CPRX is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
3.1B
Price in USD:
25.29
Share Volume:
1.1M
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
26.16
52-Week Low:
14.75
Buy
84
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 25.29 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 25.29 while CPRX 8-day exponential moving average is 24.83, which is a Buy signal.
-
The stock price of CPRX is 25.29 while Catalyst Pharmaceuticals 20-day EMA is 24.30, which makes it a Buy.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 21.15 while CPRX share price is 25.29, making it a Buy technically.
-
CPRX stock price is 25.29 and Catalyst Pharmaceuticals 200-day simple moving average is 9.81, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.17 per share, an increase this year of $0.04 per share, and an increase next year of $0.25 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is 0.79, suggesting Catalyst Pharmaceuticals is a Buy
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 62.19, which suggest Catalyst Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (23.59 - 24.87), which suggest Catalyst Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (21.88 - 24.32), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.